{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:23:57Z","timestamp":1787865837492,"version":"build-2784847793"},"reference-count":30,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are few data on the use of ceftriaxone in pregnant women diagnosed with syphilis. The aim of this study was to investigate the safety and efficacy of ceftriaxone as an alternative treatment option for syphilis during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of 79 pregnant women diagnosed with syphilis and treated with ceftriaxone was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No cases of intolerance, Jarisch-Herxheimer reactions, or allergic reactions were recorded. The average time to seronegativation for secondary syphilis with symptoms was 6.14\u00a0months \u00b1 2.76, and for latent forms, it was 7.52\u00a0months \u00b1 1.84. Patients received no additional treatment. No serious adverse drug reactions were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Data from our study support the use of ceftriaxone as an effective and safe alternative treatment for pregnant women diagnosed with syphilis when penicillin therapy is contraindicated or unavailable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09564624231206845","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T07:34:06Z","timestamp":1698046446000},"page":"130-135","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Use of ceftriaxone as an alternative treatment method in pregnant women diagnosed with syphilis \u2013 a single centre experience"],"prefix":"10.1177","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9642-9300","authenticated-orcid":false,"given":"Ilona","family":"Hartmane","sequence":"first","affiliation":[{"name":"Clinic for Dermatology and Sexually Transmitted Diseases, Riga 1st Hospital, R\u012bga, Latvia"},{"name":"Department of Dermatology and Venereology, Faculty of Medicine, R\u012bga Stradi\u0146\u0161 University, R\u012bga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iveta","family":"Ivdra","sequence":"additional","affiliation":[{"name":"Clinic for Dermatology and Sexually Transmitted Diseases, Riga 1st Hospital, R\u012bga, Latvia"},{"name":"Department of Dermatology and Venereology, Faculty of Medicine, R\u012bga Stradi\u0146\u0161 University, R\u012bga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingmars","family":"Mikazans","sequence":"additional","affiliation":[{"name":"Clinic for Dermatology and Sexually Transmitted Diseases, Riga 1st Hospital, R\u012bga, Latvia"},{"name":"Department of Dermatology and Venereology, Faculty of Medicine, R\u012bga Stradi\u0146\u0161 University, R\u012bga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksejs","family":"Princevs","sequence":"additional","affiliation":[{"name":"Clinic for Dermatology and Sexually Transmitted Diseases, Riga 1st Hospital, R\u012bga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-1693","authenticated-orcid":false,"given":"Irena","family":"Teterina","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, R\u012bga Stradi\u0146\u0161 University, R\u012bga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-8003","authenticated-orcid":false,"given":"Vanda","family":"Bondare-Ansberga","sequence":"additional","affiliation":[{"name":"Clinic for Dermatology and Sexually Transmitted Diseases, Riga 1st Hospital, R\u012bga, Latvia"},{"name":"Department of Dermatology and Venereology, Faculty of Medicine, R\u012bga Stradi\u0146\u0161 University, R\u012bga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelde","family":"Reinberga","sequence":"additional","affiliation":[{"name":"Clinic for Dermatology and Sexually Transmitted Diseases, Riga 1st Hospital, R\u012bga, Latvia"},{"name":"Department of Dermatology and Venereology, Faculty of Medicine, R\u012bga Stradi\u0146\u0161 University, R\u012bga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"bibr1-09564624231206845","unstructured":"Statistics on sexually transmitted infections. SPKC (CDCP). Available from: https:\/\/www.spkc.gov.lv\/lv\/seksuali-transmisivo-infekciju-statistika"},{"key":"bibr2-09564624231206845","doi-asserted-by":"publisher","DOI":"10.3201\/eid2305.161936"},{"key":"bibr3-09564624231206845","unstructured":"Jaun\u0101k\u0101 inform\u0101cija no Eiropas Z\u0101\u013cu a\u0123ent\u016bras par antibiotiku pieg\u0101des p\u0101rtraukumiem ES | Z\u0101\u013cu valsts a\u0123ent\u016bra. Available from: https:\/\/www.zva.gov.lv\/lv\/jaunumi-un-publikacijas\/jaunumi\/jaunaka-informacija-no-eiropas-zalu-agenturas-par-antibiotiku-piegades-partraukumiem-es"},{"key":"bibr4-09564624231206845","unstructured":"List of diagnoses and generic names of reimburesed drugs\/medical devices 2023. Available from: https:\/\/www.vmnvd.gov.lv\/lv\/media\/22197\/download?attachment"},{"key":"bibr5-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000170443.70739.cd"},{"key":"bibr6-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001050"},{"key":"bibr7-09564624231206845","unstructured":"Briggs GG, Freeman RK, Towers CV, et al. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer, 2017, p. 1646."},{"issue":"3","key":"bibr8-09564624231206845","first-page":"CD001143","volume":"2001","author":"Walker GJ","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"bibr9-09564624231206845","first-page":"375","volume":"75","author":"Klein VR","year":"1990","journal-title":"Obstet Gynecol"},{"key":"bibr10-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.11.1052"},{"key":"bibr11-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/158.4.881"},{"key":"bibr12-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103281"},{"issue":"3","key":"bibr13-09564624231206845","first-page":"14","volume":"12","author":"Radcliffe KW","year":"2001","journal-title":"J STD AIDS"},{"key":"bibr14-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1159\/000238661"},{"key":"bibr15-09564624231206845","unstructured":"Ceftriaxone SmPC. EMA. European Medicines Agency. European medicines agency. Available from: https:\/\/www.ema.europa.eu\/en"},{"key":"bibr16-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103320"},{"key":"bibr17-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008510"},{"key":"bibr18-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.10.020"},{"issue":"4","key":"bibr19-09564624231206845","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9343(84)80033-9","volume":"77","author":"Patel IH","year":"1984","journal-title":"Am J Med"},{"key":"bibr20-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-04980-1"},{"key":"bibr21-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2017.03.013"},{"issue":"1","key":"bibr22-09564624231206845","first-page":"e12750","volume":"13","author":"Mckenzie K","year":"2021","journal-title":"Cureus"},{"key":"bibr23-09564624231206845","volume-title":"Treatment and prevention of syphilis","author":"Hartmane I","year":"2004"},{"key":"bibr24-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13339.x"},{"key":"bibr25-09564624231206845","unstructured":"CDC STI Treatment Guidelines. Centers for disease control and prevention. 2022. Available from: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/default.htm"},{"key":"bibr26-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16946"},{"key":"bibr27-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.09.010"},{"key":"bibr28-09564624231206845","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.074"},{"key":"bibr29-09564624231206845","unstructured":"FDA. Ceftriaxone label. Reference ID: 3446318. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/065169s022lbl.pdf"},{"key":"bibr30-09564624231206845","volume-title":"WHO guideline on syphilis screening and treatment for pregnant women","author":"World Health Organization","year":"2017"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624231206845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09564624231206845","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624231206845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:45:05Z","timestamp":1777675505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09564624231206845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1177\/09564624231206845"],"URL":"https:\/\/doi.org\/10.1177\/09564624231206845","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]}}}